Abstract
This chapter describes some salient physiological and psychological influences on multicultural and nonverbal assessment. Obviously, examinees who require nonverbal assessment, those from culturally diverse settings and those with emotional problems and/or language deficits, may behave in ways that are different from mainstream examinees and those who present no language-related problems. Examiners who are sensitive to these differences, to the psychological impact of the testing environment, and the impact of biology on test behavior will be more successful in reducing construct-irrelevant variance in test scores and in obtaining more accurate estimates of intellectual, educational, and emotional functioning. In particular, examiners should determine whether the examinee’s physiological condition is optimal for testing; one particularly salient consideration is the extent to which medications have been administered to examinees before testing, and the dosage level; this information should be included in the psychoeducational report. In addition, if an examiner suspects that an examinee is under the influence of illicit drugs the session should be terminated until the examinee is drug free. Examiners who are aware of the conditions under which tests are administered, who can relate the impact of these influences to the success or failure of the child in the testing session, and who can extrapolate the impact of these influences to the school and home will be more successful in accurately describing performance levels and potential of the examinee, and ultimately in helping teachers and parents help children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Absorica (isotretinoin) prescribing information. (2014). Ranbaxy Laboratories Inc. Jacksonville, FL: Retrieved from http://www.absorica.com/absorica_pi.pdf
Ambien (zolpidem tartrate tablet) prescribing information. (2014). Bridgewater. NJ: Sanofi-Aventis.
American Academy of Pediatrics. (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128(5), 1007–1022. doi:10.1542/peds.2011-2654F
American Educational Research Association, American Psychological Association, & National Council on Measurement in Education. (2014). Standards for educational and psychological testing. Washington, DC: American Educational Research Association.
American Psychiatric Association. (2010). Practice guideline for the treatment of patients with major depressive disorder (3rd ed.). Washington, DC: A. J. Gelenberg, M. P. Freeman, J. C. Markowitz, J. F. Rosenbaum, M. E. Thase, M. H. Trivedi, & R. S. van Rhoads.
American Psychiatric Association. (2011). Help with addiction and substance use disorders. Retrieved from http://www.psychiatry.org/addiction
American Psychiatric Association. (2013). Attention-deficit/hyperactivity disorder. In Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. The Cochrane Database of Systematic Reviews, (1), CD003120. doi:10.1002/14651858.CD003120.pub3
Bracken, B. A. (2007). Clinical observation of preschool assessment behavior. In B. A. Bracken & R. J. Nagle (Eds.), Psychoeducational assessment of preschool children (4th ed., pp. 95–110). Mahwah, NJ: Lawrence Erlbaum Associates Inc.
Bracken, B. A., & Barona, A. (1991). State of the art procedures for translating, validating, and using psychoeducational tests in cross-cultural education. School Psychology International, 12(1–2), 119–132.
Bracken, B. A., & McCallum, R. S. (1998). Universal nonverbal intelligence test. Itasca, IL: Riverside.
Bracken, B. A., McCallum, R. S. (2016). Universal nonverbal intelligence test (2nd ed.). Itasca, IL: Riverside.
Breggin, P. R. (2013). Psychiatric drug withdrawal: A guide for prescribers, therapists, patients, and their families. New York: Springer Publishing Company.
Caffeine: Drug information. (2015). Lexicomp Online. Retrieved from https://www-uptodate-com.p.atsu.edu/contents/caffeinedruginformation?source=search_result&search=caffeine&selectedTitle=1%7E150
Carson, S., Lee, N., & Thakurta, S. (2010). Drug class review: Newer antihistamines: Final report update 2. Portland (OR): Oregon Health & Science University.
Chess, S., & Thomas, A. (1984). Origins and evolution of behavior disorders from infancy to early adult life. New York: Brunner/Mazel.
Church, M. K. (2001). H(1)-antihistamines and inflammation. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, 31(9), 1341–1343.
Cronbach, L. J. (1960). Essentials of psychological testing (2nd ed.). New York: Harper.
Fava, M., Alpert, J., Nierenberg, A. A., Mischoulon, D., Otto, M. W., Zajecka, J., et al. (2005). A double-blind, randomized trial of St John’s wort, fluoxetine, and placebo in major depressive disorder. Journal of Clinical Psychopharmacology, 25(5), 441–447. doi:10.1097/01.jcp.0000178416.60426.29.
Flanagan, D. P., Ortiz, S. O., & Alfonso, V. C. (2007). Essentials of cross-battery assessment (2nd ed.). Hoboken, NJ: Wiley.
Flanagan, D. P., Ortiz, S. O., & Alfonso, V. C. (2013). Essentials of cross-battery assessment (3rd ed.). Hoboken, NJ: Wiley.
Foradil Aerolizer (formoterol) prescribing information. (2010). Merck & Co, Inc. Whitehouse Station, NJ. Retrieved from https://www.merck.com/product/usa/pi_circulars/f/foradil/foradil_pi.pdf
Gelenberg, A. J., Freeman, M. P., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., van Rhoads, R. S. (2010). Practice guideline for the treatment of patients with major depressive disorder (3rd ed.). Washington, DC: Retrieved from the American Psychiatric Association website http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf
Gheorghiade, M., & Eichhorn, E. J. (2001). Practical aspects of using beta-adrenergic blockade in systolic heart failure (Supplemental material). The American Journal of Medicine, 110, 68–73. doi:10.1016/S0002-9343(00)00575-1.
Hendricks, E. J., & Greenway, F. L. (2011). A study of abrupt phentermine cessation in patients in a weight management program. American Journal of Therapeutics, 18(4), 292–299. doi:10.1097/MJT.0b013e3181d070d7.
Inderal XL (propranolol) prescribing information. (2015). Mist Pharmaceuticals. Cranford, NJ. Retrieved from http://inderalxl.com/wpcontent/uploads/2014/06/InderalXL_prescribing_information_highlights.pdf
Intuniv (guanfacine) prescribing information. (2015).Wayne, PA: Shire Inc.
Kagan, J. (1994a). Galen’s prophecy: temperament in human nature. New York, NY: Basic Books.
Kagan, J. (1994b). The nature of the child. New York, NY: Basic Books (Original work published 1984).
Kalikow, K. T. (2011). Kids on meds: Up-to-date information about the most commonly prescribed psychiatric medications. New York, NY: W W Norton & Co.
Kapvay (clonidine) prescribing information. (2015). St. Michael, Barbados: Concordia.
Katzung, B. G. (2015). Basic and clinical pharmacology. New York: McGraw-Hill Education.
Ko, D. T., Hebert, P. R., Coffey, C. S., Sedrakyan, A., Curtis, J. P., & Krumholz, H. M. (2002). Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. Journal of the American Medical Association, 288(3), 351–357.
Labbate, L. A., Rosenbaum, J. F., Fava, M., & Arana, G. W. (2010). Handbook of psychiatric drug therapy (6th ed.). Philadelphia: Lippincott Williams & Wilkins.
Lejoyeux, M., & Adès, J. (1997). Antidepressant discontinuation: A review of the literature (Supplemental material). Journal of Clinical Psychiatry, 58, 11–16.
Lithobid (lithium carbonate) prescribing information. (2014). Baudette, MN: Ani Pharmaceuticals.
McLoughlin, J. A., & Lewis, R. B. (2008). Assessing students with special needs (7th ed.). Upper Saddle River, NJ: Pearson.
Orwell, G. (1946). Animal Farm. New York: Harcourt Broace Jovanovich.
Ousler, G. W., Wilcox, K. A., Gupta, G., Abelson, M. B., & Fink, K. (2004). An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride. Annals of Allergy, Asthma & Immunology, 93(5), 460–464. doi:10.1016/S1081-1206(10)61413-5.
Plomin, R., Owen, M. J., & McGuffin, P. (1994). The genetic basis of complex human behaviors. Science, 264, 1733–1739.
Pool, R. (1997). Portrait of a gene guy. Discover, 51–57.
Proventil HFA (Albuterol sulfate) inhalation aerosol prescribing information. (2012) Merck & Co., Inc. Whitehouse Station, NJ. Retrieved from https://www.merck.com/product/usa/pi_circulars/p/proventil_hfa/proventil_hfa_pi.pdf
Provigil (modafinil) prescribing information. (2015). Teva Pharmaceuticals. North Wales, PA. Retrieved from http://www.provigil.com/media/pdfs/prescribing_info.pdf
Pseudoephedrine: drug information. (2015). Lexicomp Online. Retrieved from https://www-uptodate-com.p.atsu.edu/contents/pseudoephedrine-drug-information?source=search_result&search=pseudoephedrine&selectedTitle=1%7E140
Rayos (prednisone) prescribing information. (2013). Horizon Pharma, Deerfield, IL. Retrieved from http://www.rayosrx.com/PI/RAYOS-Prescribing-Information.pdf
Santos de Barona, M., & Barona, A. (2007). Assessing multicultural preschool children. In B. A. Bracken & R. J. Nagle (Eds.), Psychoeducational assessment of preschool children (4th ed., pp. 69–92). Mahwah, NJ: Lawrence Erlbaum Associates Inc.
Sattler, J. M. (2008). Assessment of children: Cognitive foundations (5th ed.). San Diego, CA: Jerome M. Sattler, Publisher Inc.
Serevent Diskus (salmeterol xinafoate inhalation powder) prescribing information. (2014). GlaxoSmithKline. Research Triangle Park, NC. Retrieved from https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Serevent_Diskus/pdf/SEREVENT-DISKUS-PI-MG.PDF
Shelton, R. C. (2001). Steps following attainment of remission: Discontinuation of antidepressant therapy. Primary Care Companion to the Journal of Clinical Psychiatry, 3(4), 168–174.
Shelton, R. C., Keller, M. B., Gelenberg, A., Dunner, D. L., Hirschfeld, R., Thase, M. E., … Halbreich, U. (2001). Effectiveness of St John’s wort in major depression: a randomized controlled trial. Journal of the American Medical Association, 285(15), 1978–1986.
Simons, F. E., & Simons, K. J. (1999). Clinical pharmacology of new histamine H1 receptor antagonists. Clinical Pharmacokinetics, 36(5), 329–352.
Sternberg, R. J., & Grigorenko, E. L. (2001). Ability testing across cultures. In L. A. Suzuki, J. G. Ponterotto, & P. J. Meller (Eds.), Handbook of multicultural assessment: Clinical, psychological, and educational applications (2nd ed., pp. 335–358). San Francisco: Jossey-Bass.
Takushi, R., & Uomoto, J. M. (2001). The clinical interview from a multicultural perspective. In L. A. Suzuki, J. G. Ponterotto, & P. J. Meller (Eds.), Handbook of multicultural assessment: Clinical, psychological, and educational applications (2nd ed., pp. 47–66). San Francisco: Jossey-Bass.
Tenormin (atenolol) prescribing information. (2012). AstraZeneca Pharmaceuticals. Wilmington, DE. Retrieved from http://www1.astrazeneca-us.com/pi/tenormin.pdf
Thomas, A., Chess, S., & Birch, H. G. (1968). Temperament and behavior disorders in children. New York, NY: New York University Press.
Toprol XL (metoprolol) prescribing information. (2014). AstraZeneca Pharmaceuticals. Wilmington, DE. Retrieved from http://www1.astrazeneca-us.com/pi/toprol-xl.pdf
van Geffen, E. G., Hugtenburg, J. G., Heerdink, E. R., van Hulten, R. P., & Egberts, A. G. (2005). Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. European Journal of Clinical Pharmacology, 61(4), 303–307.
Verster, J. C., & Volkerts, E. R. (2004). Antihistamines and driving ability: Evidence from on-the-road driving studies during normal traffic. Annals of Allergy, Asthma & Immunology, 92(3), 294–304. doi:10.1016/S1081-1206(10)61566-9
Weber, W., Stoep, A. V., McCarty, R. L., Weiss, N. S., Biederman, J., & McClellan, J. (2008). Hypericum perforatum (St John’s wort) for attention-deficit/hyperactivity disorder in children and adolescents: A randomized controlled trial. JAMA Journal of The American Medical Association, 299(22), 2633–2641. doi:10.1001/jama.299.22.2633
Wernicke, J. F., Adler, L., Spencer, T., West, S. A., Allen, A. J., Heiligenstein, J., … Michelson, D. (2004). Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: A prospective, placebo-controlled assessment. Journal of Clinical Psychopharmacology, 24(1), 30–35. doi:10.1097/01.jcp.0000104907.75206.c2
Wilens, T. E. (1999). Straight talk about psychiatric medications for kids. New York: The Guilford Press.
Zebeta (bisoprolol) prescribing information. (2010). Duramed Pharmaceuticals. Pomona, NY. Retrieved from http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a11548a0-9c0f-4729-907c-75d8f99a6c85
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
McCallum, R.E., McCallum, R.S. (2017). Psychological and Physiological Influences on Multicultural and Nonverbal Assessment. In: McCallum, R. (eds) Handbook of Nonverbal Assessment. Springer, Cham. https://doi.org/10.1007/978-3-319-50604-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-50604-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50602-9
Online ISBN: 978-3-319-50604-3
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)